We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Polymeric Absorbable Suture

By HospiMedica staff writers
Posted on 24 Apr 2007
An absorbable suture is the first medical device derived from a new class of biopolymers produced by recombinant DNA technology.

The absorbable suture is made from TephaFlex, a member of the new class of biopolymers, which have mechanical and biological properties that are uniquely applicable to implantable medical devices. More...
Compared to synthetic polymers such as polylactic acid (PLA) and polyglycolic acid (PGA), TephaFlex material is tougher and more flexible, with an absorption rate and degradation profile that are compatible with human tissue repair and replacement applications. However, unlike other biopolymers such as collagen and hyaluronate, TephaFlex is thermoplastic and can be fabricated into virtually any shape or form--including fibers, films, tubes, foams, textiles, microspheres, and molded constructs--using a wide range of conventional melt and solvent processing techniques.

The absorbable suture is one of the strongest absorbable fibers known, offering up to 50% greater tensile strength than monofilament absorbable sutures. In addition to high strength, the suture also offers surgeons improved flexibility, good knot security, and prolonged strength retention when implanted. The TephaFlex absorbable suture is a product of Tepha (Cambridge, MA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"We are delighted that the FDA has cleared the TephaFLEX absorbable suture,” said Dr. Simon Williams, President and CEO of Tepha. "The company's novel biopolymer technology can now be further applied to the development of a range of medical devices to meet unmet clinical needs.”


Related Links:
Tepha

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Mask
Respire SOFT
New
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.